Industry / Pharmaceutical Preparation Manufacturing
Trending Companies
Latest filings
424B3
KZIA
Kazia Therapeutics Limited
17 May 24
Prospectus supplement
4:07pm
DEFR14A
TRVN
Trevena
17 May 24
Revised proxy
4:05pm
6-K
KZIA
Kazia Therapeutics Limited
17 May 24
Current report (foreign)
4:05pm
6-K
GSK
GSK
17 May 24
Current Report
11:16am
6-K
MOR
Morphosys
17 May 24
Current report (foreign)
10:15am
25-NSE
ABBV
Abbvie
17 May 24
Exchange delisting
9:03am
6-K
GSK
GSK
17 May 24
GSK Completes Sale of Shares In Haleon PLC
6:00am
SC 13D/A
SYBX
Synlogic
16 May 24
SYNLOGIC / New Enterprise Associates 14 ownership change
7:44pm
SC 14D9/A
MOR
Morphosys
16 May 24
Tender offer solicitation (amended)
4:43pm
SC TO-T/A
MOR
Morphosys
16 May 24
Third party tender offer statement (amended)
4:31pm
Upcoming Earnings Releases
AZN
Astrazeneca
$206,342.1 mm
25 Jul 24
MRK
Merck & Co
$301,270.0 mm
30 Jul 24
GSK
GSK
$81,560.8 mm
31 Jul 24
UTHR
United Therapeutics
$10,238.5 mm
31 Jul 24
GMAB
Genmab
$19,146.4 mm
1 Aug 24
MED
Medifast
$580.4 mm
5 Aug 24
SUPN
Supernus Pharmaceuticals
$1,510.6 mm
6 Aug 24
MOR
Morphosys
$1,379.7 mm
7 Aug 24
JAZZ
Jazz Pharmaceuticals
$7,336.7 mm
7 Aug 24
EBS
Emergent Biosolutions
$94.9 mm
8 Aug 24
Stock splits Upcoming and recent stock splits
News
AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst
ABBV
BMY
17 May 24
10 Health Care Stocks Whale Activity In Today's Session
ARDX
BPMC
CYTK
17 May 24
GSK Completely Exits Sensodyne Toothpaste Maker Haleon In $1.6B Sale
GSK
HLN
PFE
17 May 24
The Analyst Verdict: AbbVie In The Eyes Of 5 Experts
ABBV
17 May 24
AbbVie Says It Will Present New Data Supporting Leading Gastroenterology Portfolio At 2024 Digestive Disease Week; Company To Present 15 Abstracts, Including Three Oral Presentations, In Crohn's Disease And Ulcerative Colitis
ABBV
17 May 24
Cantor Fitzgerald Initiates Coverage On AbbVie with Overweight Rating, Announces Price Target of $200
ABBV
17 May 24
Check Out What Whales Are Doing With MRK
MRK
16 May 24
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,000 Today
ABBV
16 May 24
GSK Announces Intention To Sell ~385M Shares In Haleon
GSK
HLN
16 May 24
AstraZeneca's COVID-19 Prevention Therapy Cuts Risk Of Infection In Patients With Weaker Immunity, Data Shows
AZN
16 May 24
Press releases
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week®
ABBV
17 May 24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
SUPN
16 May 24
Trevena Reports First Quarter 2024 Results and Provides Business Update
TRVN
15 May 24
Merck to Present New Data at 2024 ASCO Annual Meeting Demonstrating Advancements in Novel Oncology Treatment Approaches Across Broad Portfolio and Diverse Pipeline
MRK
15 May 24
Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress
GMAB
14 May 24
Synlogic Reports First Quarter 2024 Financial Results
SYBX
14 May 24
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
SUPN
13 May 24
AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders
ABBV
13 May 24
Merck Provides Update on Phase 3 KeyVibe-010 Trial Evaluating an Investigational Coformulation of Vibostolimab and Pembrolizumab as Adjuvant Treatment for Patients With Resected High-Risk Melanoma
MRK
13 May 24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
SUPN
12 May 24
Transcripts
SUPN
Earnings call transcript
2024 Q1
8 May 24
ABCL
Earnings call transcript
2024 Q1
7 May 24
AXSM
Earnings call transcript
2024 Q1
6 May 24
EBS
Earnings call transcript
2024 Q1
1 May 24
JAZZ
Earnings call transcript
2024 Q1
1 May 24
UTHR
Earnings call transcript
2024 Q1
1 May 24
ABBV
Earnings call transcript
2024 Q1
26 Apr 24
MRK
Earnings call transcript
2024 Q1
25 Apr 24
IGXT
Earnings call transcript
2023 Q4
21 Mar 24
EBS
Earnings call transcript
2023 Q4
6 Mar 24
Patents
Utility
Modified Imidazopyridines As Glucosylceramide Synthase Inhibitors
MRK
18 Jan 24
Utility
Antibodies Targeting C5AR
MOR
18 Jan 24
Utility
Modulators of the Integrated Stress Pathway
ABBV
18 Jan 24
Utility
GHB Formulation and Method for Its Manufacture
JAZZ
18 Jan 24
Utility
Polycyclic Cap-dependent Endonuclease Inhibitors for Treating or Preventing Influenza
MRK
18 Jan 24
Utility
Methods of administering solriamfetol to lactating women
AXSM
16 Jan 24
Utility
Well plate assembly with pressure release mechanism
MRK
16 Jan 24
Utility
Methods of administering solriamfetol to lactating women
AXSM
16 Jan 24
Utility
Combination of an ANTI-CD19 Antibody and a Bruton's Tyrosine Kinase Inhibitor and Uses Thereof
MOR
11 Jan 24
Utility
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF
ABBV
11 Jan 24
Reddit threads
Daily Discussion Thread - May 17th, 2024
CTHR
HSCS
WHLR
17 May 24
Experiment #025613 - My investment journey
EBS
ACGL
NMS
17 May 24
Low-risk, low-return strategy discussion
ORLY
OXY
AZN
16 May 24
Biden rescheduling Marijuana has insane implications
DEA
BCAN
PORT
16 May 24
Daily Discussion Thread - May 16th, 2024
DRMA
ELWS
SEEL
16 May 24
Anyone know what is up with ABBV?
ABBV
15 May 24
Daily Discussion Thread - May 15th, 2024
BNR
AC
ACXP
15 May 24
Feedback appreciatedu
STAG
AGNC
PG
14 May 24
Active managers of r/investing what are your top 10 holdings and how are you doing this year? Are you beating your bogie?
INVE
EVO
MSFT
14 May 24
What old Investments do you still think about?
AMD
NVDA
GE
14 May 24